– AIC100 ICAM-1 Targeting CAR T Cell Therapy Recognized as Top Global Advance Made by Small Biotechnology Companies – NATICK, Mass. and LONDON, Nov. 17, 2023 /PRNewswire/ — AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.